$30 Million Industry-friendly Plan Moves Forward at California Stem Cell Agency
SAN FRANCISCO – A key panel of directors of the $3 billion California stem cell agency this morning approved a $30 million effort to speed development of therapies and to reach out to the biotech industry.
The new initiative was approved with little discussion at a brief teleconference meeting of the new Intellectual Property Subcommittee.The proposal wi…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.